Bellerophon Therapeutics, Inc. Made Headway

Thu, Jan 05, 2023 at 07:02 PM
Bellerophon Therapeutics, Inc. Made Headway

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $2.29, representing a gain of 160.2%. On Thu, Jan 05, 2023, BLPH:NASDAQ hit a New 2-Week High of $2.29. The stock appeared on our News Catalysts scanner on Thu, Jan 05, 2023 at 10:43 AM in the 'AGREEMENT' category. From Thu, Dec 22, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days

The stock spiked on Thu, Jan 05, 2023 at $3.5 with a volume of 58M+.

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.